EMA — authorised 11 March 2010
- Status: approved
🇪🇺 Promacta in European Union
EMA authorised Promacta on 11 March 2010
Marketing authorisation
Promacta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Promacta approved in European Union?
Yes. EMA authorised it on 11 March 2010.
Who is the marketing authorisation holder for Promacta in European Union?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.